Key Developments: C R Bard Inc (BCR)
112.22USD
19 Jun 2013
$0.42 (+0.38%)
$111.80
$111.77
$112.22
$111.44
204,200
656,010
$112.28
$93.69
Latest Key Developments (Source: Significant Developments)
C R Bard Inc Increases Quarterly Dividend; Announces $500 Million Share Repurchase Authorization
C R Bard Inc announced that it has increased the quarterly dividend on Bard's common stock by 5%, to $0.21 per share. The dividend is payable on August 2, 2013 to shareholders. The Company also authorized the repurchase of up to $500 million of the Company's common stock. This is in addition to approximately $30 million remaining under the June 2012 authorization. Share repurchases will be made from time-to-time in the open market or through privately negotiated transactions. Full Article
C R Bard Inc To Pay $48 Million To Settle Kickback Allegations-Reuters
Reuters reported that C R Bard Inc will pay about $48.3 million to resolve allegations it made illegal payments to hospitals and physicians to entice them to buy its radiation treatment for prostate cancer, the Justice Department (DOJ) said. The illegal payments allegedly took the form of grants, rebates, conference fees, marketing assistance and free medical equipment that Bard provided between 1998 and 2006 to customers who used its brachytherapy seeds to treat prostate cancer, DOJ said. Full Article
C R Bard Inc Issues Q2 2013 EPS Guidance Below Analysts' Estimates-Conference Call
C R Bard Inc announced that for second quarter of 2013, it expects adjusted earnings per share (EPS) to be between in the range of $1.35 to $1.39. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $1.46 for the second quarter of 2013. Full Article
C R Bard Inc Declares Quarterly Dividend
C R Bard Inc announced that it has declared a regular quarterly dividend of 20 cents per share on Bard's common stock. The current indicated annual dividend rate is 80 cents per share. The dividend is payable on May 10, 2013 to shareholders of record at the close of business on April 29, 2013. Full Article
C R Bard Inc Issues Q1 2013 EPS Guidance Below Analysts' Estimates; Comments On Q1 2013 Revenue Guidance; Issues FY 2013 Guidance Mixed Guidance; Comments On FY 2014 EPS Guidance-Conference Call
C R Bard Inc announced that for first quarter of 2013, it expects adjusted earnings per share (EPS) between $1.40 and $1.44 per share on flattish sales growth. For fiscal 2013, it expects constant currency revenue growth to be 2%-5% and adjusted EPS in the range of $6.25-$6.30. For fiscal 2014, it expects adjusted EPS growth to be between 22% and 25%. The Company reported revenue of $2.958 billion in fiscal 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $1.54 on revenue of $741 million for first quarter of 2013; revenue of $3.06 billion and EPS of $6.73 for fiscal 2013; EPS of $7.63 for fiscal 2014. Full Article
C R Bard Inc Declares Quarterly Dividend
C R Bard Inc announced that the Board of Directors declared a regular quarterly dividend of 20 cents per share on Bard's common stock. The current indicated annual dividend rate is 80 cents per share. The dividend is payable on February 1, 2013 to shareholders of record at the close of business on January 22, 2013. Full Article
C R Bard Inc Declares Quarterly Dividend
C R Bard Inc announced that it has declared a regular quarterly dividend of 20 cents per share on Bard's common stock. The current indicated annual dividend rate is 80 cents per share. The dividend is payable on November 2, 2012 to shareholders of record at the close of business on October 22, 2012. Full Article
C R Bard Inc Comments On Q3 2012 Revenue Guidance; Issues Q3 2012 EPS Guidance In Line With Analysts' Estimates-Conference Call
C R Bard Inc announced that for third quarter of 2012, it expects constant currency sales growth to be 3%-5% and earnings per share (EPS) guidance, excluding certain items, to be $1.60-$1.64. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $744 million and EPS of $1.66 for third quarter of 2012. Full Article
C R Bard Inc Announces $500 Million Share Repurchase Authorization; Increases Quarterly Dividend
C R Bard Inc announced that it authorized the repurchase of up to $500 million of the Company’s common stock. This is in addition to approximately $88 million remaining under the June 2010 authorization. Share repurchases will be made from time-to-time in the open market or through privately negotiated transactions. The Board of Directors increased the quarterly dividend on Bard's common stock by 5%, to $0.20 per share. The dividend is payable on August 3, 2012 to shareholders of record at the close of business on July 23, 2012. Full Article
C R Bard Inc Names Christopher S. Holland Senior Vice President and Chief Financial Officer
C R Bard Inc announced that Christopher S. Holland has been named Senior Vice President and Chief Financial Officer, effective May 21, 2012. Full Article
C R Bard to pay $48 million to settle kickback allegations, DOJ says
- Medical device maker C.R. Bard Inc will pay about $48.3 million to resolve allegations it made illegal payments to hospitals and physicians to entice them to buy its radiation treatment for prostate cancer, the Justice Department said.
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
